WEILL DAVID sold 61.6% of their position (21.64K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $1.21M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/14/2022ACC: 0000899243-22-035755
-21.64K
Net shares
Net seller
$1.21M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
21.64K acquired · 43.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+21.64K
Price / share
$16.00
Trade value
$346.32K
% of position
160.3%
11/10/2022
13.50K→35.15K
Common Stock
Direct
Shares
−21.64K
Price / share
$56.00
Trade value
$1.21M
% of position
61.6%
11/10/2022
35.15K→13.50K
Total
Net shares
+0.00
Net value
-$865.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2022 | M · Option Exercise | +21.64K | $16.00 | $346.32K | 160.3% | 13.50K | 35.15K |
| Common Stock Direct | 11/10/2022 | S · Sale | −21.64K | $56.00 | $1.21M | 61.6% | 35.15K | 13.50K |
| Total | +0.00 | -$865.80K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
21.64K shares
Shares
−21.64K
Strike price
16.00
Held after
0.00
Exercisable
—
11/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock21.64K shares | 11/10/2022 | M · Option Exercise | −21.64K | 16.00 | — | 0.00 |